There are three ongoing ICI Trials testing optimal perturbation of the tumor immune system and rate of pathologic response, this are the NESCIO trial, the SPARC-1 and NAPSTER. The NESCIO trial ...
In the journal “Science Translational Medicine”, scientists from DZNE and LMU Hospital report on new insights into the mechanisms of “Niemann-Pick type C” (NPC), a rare neurodegenerative disease ...